Addex Therapeutics Ltd/ CH0029850754 /
| 2024-10-28 4:59:27 PM | Chg. - | Volume | Bid9:10:30 AM | Ask4:12:33 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 0.078CHF | - | 1,019 Turnover: 79.482 |
-Bid Size: - | -Ask Size: - | 11.41 mill.CHF | - | - |
Assets
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 0.0000 | 27.6000 | .1000 | .1000 | .0400 | ||||||
| Intangible Assets | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Long-Term Investments | 0.0000 | 68.9000 | .1000 | .1000 | - | ||||||
| Fixed Assets | 0.0000 | 639.9000 | .7000 | .6000 | .4500 | ||||||
| Inventories | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Accounts Receivable | - | - | - | - | .4200 | ||||||
| Cash and Cash Equivalents | 41.7000 | 31.5000 | 18.7000 | 20.5000 | 6.9600 | ||||||
| Current Assets | 42.2000 | 32.4000 | 19.5000 | 21.9000 | 7.8200 | ||||||
| Total Assets | 42.2000 | 33 | 20.2000 | 22.5000 | 8.2800 | ||||||
Liabilities
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 2.1000 | 4.2000 | 2.5000 | 3.8000 | 2.9900 | ||||||
| Long-term debt | - | - | - | - | - | ||||||
| Liabilities to Banks | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Provisions | - | - | - | - | - | ||||||
| Liabilities | 2.9000 | 7.5000 | 5.6000 | 5.6000 | 3.3700 | ||||||
| Share Capital | 28.6000 | 32.8000 | 32.8000 | 49.3000 | - | ||||||
| Total Equity | 39.2000 | 25.5000 | 14.6000 | 16.9000 | 4.9100 | ||||||
| Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Total liabilities equity | 42.2000 | 33 | 20.2000 | 22.5000 | 8.2800 | ||||||
Income Statement
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 6.7000 | 2.9000 | 3.9000 | 3.1000 | 1.4000 | ||||||
| Depreciation (total) | - | - | - | - | - | ||||||
| Operating Result | -1.4000 | -14.6000 | -12.2000 | -15.5000 | -20.5000 | ||||||
| Interest Income | - | - | - | - | - | ||||||
| Income Before Taxes | -1.6000 | -14.8000 | -12.9000 | -15.4000 | - | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Net Income | -1.6000 | -14.8000 | -12.9000 | -15.4000 | -20.8000 | ||||||
Per Share
Cash Flow
| 2018 IFRS in mill. CHF |
2019 IFRS in mill. CHF |
2020 IFRS in mill. CHF |
2021 IFRS in mill. CHF |
2022 IFRS in mill. CHF |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 1.8000 | -9.5000 | -12.2000 | -14.7000 | -16.4300 | ||||||
| Cash Flow from Investing Activities | -.0600 | -.0400 | -.0600 | -.0300 | .0030 | ||||||
| Cash Flow from Financing | 37.4000 | -.5000 | .0500 | 16.4000 | 3.1000 | ||||||
| Decrease / Increase in Cash | 39.1000 | -10 | -12.2000 | 1.7000 | - | ||||||
| Employees | 17 | 23 | 27 | 28 | 24 | ||||||
